Cannara Biotech Achieves Its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

GlobeNewswireAug 16 21:00

Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure

BenzingaJul 24 02:06

Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss

BenzingaMay 2 03:45

Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51%

MT NewswiresApr 30 03:43

Press Release: Cannara Biotech Reports Q2 2024 Financial Results

Dow JonesApr 30 03:00

Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market...

Stockhouse Jan 30 21:30